InsiderTradesSIGMA

InsidersTradesSigma

H. Lundbeck A/S (HLUN-B.CO) — directors' dealings · Healthcare · MAR

← Companies ★ Sign in to follow

H. Lundbeck A/S: directors' dealings · Denmark · Finanstilsynet DK

DK:h-lundbeck-asDK0061804697DK·Finanstilsynet DKMcap 39.8Bn€Healthcare

Explore the full directors' dealings record of H. Lundbeck A/S, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare sector, H. Lundbeck A/S has published 63 insider filings. Market capitalisation: €39.8bn. The latest transaction was disclosed on 16 February 2024 — Purchase. Among the most active insiders: Unknown. All data is free.

63

Insider Decl.

0

Thresholds

€923,063

30 ops.

Buy Volume

€18m

17 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

40.14 €

Analyst consensus

12 analysts

Buy

34.00 €Target 47.21 €(+18%)65.00 €

Income statement

Revenue24.63 Bn€

Gross profit20.36 Bn€83% margin

Net income3.19 Bn€14.6% margin

Valuation

PER (trailing)10.7x

PER (forward)6.6x

P/Book1.6x

Beta0.26

Balance sheet & cash

Market cap39.82 Bn€

Total debt11.65 Bn€

Free Cash Flow4.86 Bn€

Debt / Equity43%

Profitability & ownership

ROE14.9%

ROA7.5%

% insiders0.1%

% institutions79.2%

Last declaration on 16 February 2024

All Executives63 Thresholds Prospectus Other

Declarations63 total

Executives●Purchase8DK FSA

U

€100,68522,529 shares@ €4.46910.0003% mcap0.3% of flow

Share

DK:1275549·15 Feb 2024

Ideal exit: 11 Nov 2024 (T+270)

Executives●Other8DK FSA

U

06,737 shares0

Share

DK:1273307·7 Feb 2024

Executives●Purchase5DK FSA

U

€33,7591,679 shares@ €20.10680.0001% mcap0.1% of flow

Share

DK:1139553·11 Feb 2022

Ideal exit: 8 Nov 2022 (T+270)

Executives●Purchase5DK FSA

U

€67,0683,385 shares@ €19.81330.0002% mcap0.2% of flow

Share

DK:1139190·10 Feb 2022

Ideal exit: 7 Nov 2022 (T+270)

Executives●Purchase8DK FSA

U

€65,6262,439 shares@ €26.90680.0002% mcap0.2% of flow

Share

DK:1033638·25 May 2021

Ideal exit: 19 Feb 2022 (T+270)

Executives●Grant8DK FSA

U

ShareIssued by Lundbeck LLC

DK:924852·2 Mar 2020

Executives●Other8DK FSA

U

Share

DK:920591·6 Feb 2020

Executives●Purchase8DK FSA

U

€40,3601,225 shares@ €32.94670.0001% mcap0.1% of flow

Share

DK:910897·11 Nov 2019

Ideal exit: 7 Aug 2020 (T+270)

Executives●Sale8DK FSA

U

€1m29,500 shares@ €35.88250.0027% mcap3.1% of flow

Share

DK:891142·21 May 2019

Executives●Sale8DK FSA

U

€142,8234,000 shares@ €35.70580.0004% mcap0.4% of flow

Share

DK:890977·20 May 2019

Executives●Purchase8DK FSA

U

€127,7823,500 shares@ €36.50930.0003% mcap0.4% of flow

Share

DK:889374·9 May 2019

Ideal exit: 3 Feb 2020 (T+270)

Executives●Sale10DK FSA

U

€4m80,000 shares@ €47.40440.0095% mcap11.1% of flow

ShareNASDAQ Copenhagen XCSE

DK:811725·21 Nov 2017

Executives●Other9DK FSA

U

€2m100,000 shares@ €20.98630.0053% mcap6.2% of flow

ShareOutside a trading venue (the shares will be listed on

DK:811147·17 Nov 2017

Executives●Sale8DK FSA

U

ShareNASDAQ Copenhagen XCSE

DK:789043·28 Aug 2017

Executives●Sale13DK FSA

U

€8m150,000 shares@ €52.1170.020% mcap22.9% of flow

Share

DK:788844·23 Aug 2017

Executives●Other10DK FSA

U

€3m160,000 shares@ €20.99730.0084% mcap9.9% of flow

Share

DK:787682·18 Aug 2017

Executives●Sale8DK FSA

U

€1m22,927 shares@ €51.11990.0029% mcap3.4% of flow

Share

DK:786811·10 Aug 2017

Executives●Sale8DK FSA

U

€1m23,500 shares@ €49.74210.0029% mcap3.4% of flow

Share

DK:786533·10 Aug 2017

Executives●Other13DK FSA

U

€8m400,000 shares@ €20.9910.021% mcap24.6% of flow

ShareOutside a trading venue (the shares will be listed on

DK:775541·17 May 2017

Executives●Sale8DK FSA

U

€908,93519,796 shares@ €45.91510.0023% mcap2.7% of flow

ShareNASDAQ Copenhagen XCSE

DK:774449·11 May 2017

Executives●Purchase8DK FSA

U

€487,78315,000 shares@ €32.51890.0012% mcap1.4% of flow

ShareNASDAQ Copenhagen XCSE

DK:744665·7 Nov 2016

Ideal exit: 4 Aug 2017 (T+270)

Executives●Sale8DK FSA

U

UnknownEngineering

€411,98112,500 shares@ €32.95850.0010% mcap1.2% of flow

ShareNASDAQ Copenhagen XCSE

DK:744306·3 Nov 2016

Executives●Sale8DK FSA

U

€1m39,939 shares@ €35.19980.0035% mcap4.1% of flow

ShareNASDAQ Copenhagen XCSE

DK:726955·9 Sept 2016

Executives●Other8DK FSA

U

€722,46242,478 shares@ €17.00790.0018% mcap2.1% of flow

ShareNASDAQ Copenhagen XCSE

DK:724724·25 Aug 2016

Executives●Other8DK FSA

U

€722,46242,478 shares@ €17.00790.0018% mcap2.1% of flow

ShareH. Lundbeck A/S (the subscribed for shares will be registered on

DK:724717·25 Aug 2016

25 of 63 declarations

About H. Lundbeck A/S

H. Lundbeck A/S is a Danish pharmaceutical company focused on developing treatments for psychiatric and neurological disorders. It emphasizes innovation in medications for conditions such as depression and schizophrenia.